-
公开(公告)号:US12048710B2
公开(公告)日:2024-07-30
申请号:US17672508
申请日:2022-02-15
Applicant: The Regents of the University of California
Inventor: Carolyn Ruth Bertozzi , Nicholas J. Agard , Jennifer A. Prescher , Jeremy Michael Baskin , Ellen May Sletten
IPC: G01N33/531 , A61K31/655 , C07C45/29 , C07C45/51 , C07C45/63 , C07C49/457 , C07C49/753 , C07C57/26 , C07C59/72 , C07C63/66 , C07C63/74 , C07C69/708 , C07C69/76 , C07D207/416 , C07D207/452 , C07D225/02 , C07D249/16 , C07D495/04 , G01N33/68
CPC classification number: A61K31/655 , C07C45/292 , C07C45/511 , C07C45/63 , C07C49/457 , C07C49/753 , C07C57/26 , C07C59/72 , C07C63/66 , C07C63/74 , C07C69/708 , C07C69/76 , C07D207/416 , C07D207/452 , C07D225/02 , C07D249/16 , C07D495/04 , G01N33/531 , G01N33/6803 , G01N33/6842 , C07C2601/18 , C07C45/292 , C07C49/753 , C07C45/511 , C07C49/457 , C07C45/511 , C07C49/753 , C07C45/511 , C07C49/573 , C07C45/63 , C07C49/457
Abstract: The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
-
公开(公告)号:US20240124385A1
公开(公告)日:2024-04-18
申请号:US18516407
申请日:2023-11-21
Applicant: CORSAIR PHARMA, INC.
Inventor: Xiaoming ZHANG , Meenakshi S. VENKATRAMAN , Cyrus K. BECKER
IPC: C07C69/734 , A61K9/70 , C07C53/136 , C07C59/11 , C07C59/13 , C07C69/28 , C07C69/675 , C07C69/68 , C07C69/708 , C07C69/712 , C07C69/74 , C07C69/75 , C07C69/96 , C07D305/08 , C07D307/24 , C07D307/30 , C07D309/08
CPC classification number: C07C69/734 , A61K9/7023 , C07C53/136 , C07C59/11 , C07C59/13 , C07C69/28 , C07C69/675 , C07C69/68 , C07C69/708 , C07C69/712 , C07C69/74 , C07C69/75 , C07C69/96 , C07D305/08 , C07D307/24 , C07D307/30 , C07D309/08 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2603/14
Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US20220259402A1
公开(公告)日:2022-08-18
申请号:US17346776
申请日:2021-06-14
Applicant: EVOCO LIMITED
Inventor: Jason James Robinson , Radu Lucian Vicol , Juri Helmut Moebus , Tristan Calayan , Guerino G. Sacripante
IPC: C08K5/11 , C08G63/16 , C07C69/708 , C08G18/18 , C08G18/42 , C07C69/734 , C08G18/73 , C07C69/40 , C07C69/50
Abstract: A composition comprised of a component selected from the group consisting of a biobased bis-alkyl succinate and a biobased bis-alkyl sebacate, each derived, for example, from the esterification of biobased diacid such as succinic acid or sebacic acid, and a biobased alcohol and a biobased polyester.
-
公开(公告)号:US11339114B2
公开(公告)日:2022-05-24
申请号:US15985305
申请日:2018-05-21
Applicant: RestorTears, LLC
Inventor: Daniel M. Albert , Arthur S. Polans
IPC: C07C69/708 , C07C69/28 , C07C69/593 , A61K45/06 , A61K9/00 , A61K31/22 , A61K31/225
Abstract: The present invention is directed to pharmaceutical compositions comprising compounds found in Harderian gland secretions, a method of treating dry eye in a human comprising ophthalmically administering an effective amount of a compound, e.g. a lipid compound, found in Harderian gland secretions, pharmaceutical compositions comprising said lipid compounds, as identified by characteristic chemical data and mass spectra of said lipid compounds, said lipid compound in essentially pure form, and an ophthalmic vehicle comprising a therapeutic agent and a compound present in the secretions of the Harderian gland, e.g. a lipid compound, found in the secretions of the Harderian gland, e.g. a rabbit Harderian gland.
-
5.
公开(公告)号:US11193079B2
公开(公告)日:2021-12-07
申请号:US15930012
申请日:2020-05-12
Applicant: ExxonMobil Research and Engineering Company
Inventor: Abhimanyu O. Patil , Satish Bodige , Kyle G. Lewis
IPC: C10M129/76 , C10M105/34 , C07C69/708 , C07C67/48 , C10N30/00 , C10N20/00 , C10N20/02 , C10N40/25
Abstract: Compositions include ether ester compounds derived from neo-acids, lubricating oil base stocks containing such ester compounds, and lubricating oil compositions containing such ester compounds. Methods can include making and formulating compositions containing ether ester compounds derived from neo-acids.
-
公开(公告)号:US11104654B2
公开(公告)日:2021-08-31
申请号:US16509963
申请日:2019-07-12
Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
Inventor: Thomas S. Scanlan , Andrew Placzek , Tapasree Banerji , Sky Ferrara , James Matthew Meinig
IPC: C07D295/088 , C07C219/06 , C07C229/36 , C07C235/06 , C07C237/08 , C07C69/736 , C07H13/04 , A61P25/00 , C07C69/708 , C07C229/08 , C07C237/12 , C07D205/04 , C07D207/08 , C07D211/22 , C07D211/42 , C07D211/44 , C07D233/64 , C07D309/10
Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
-
公开(公告)号:US20210230495A1
公开(公告)日:2021-07-29
申请号:US15734644
申请日:2019-06-05
Inventor: Stephanie DE OLIVEIRA SOUZA , Rosana Maria ALVES SABOYA , Jose Andre CAVALCANTI DA SILVA , Italo CASTRO RIOS , Francisco Murilo TAVARES DE LUNA , Fatima Andrea LIMA GIRAO , Celio LOUREIRO CAVALCANTE JUNIOR
IPC: C10M105/42 , C10M105/40 , C10M177/00 , C07C69/708 , C07C67/08
Abstract: The present invention describes a process for obtaining a biolubricant from vegetable oil, which comprises the steps of (a) esterification reaction of the product of vegetable oil hydrolysis using a branched aliphatic alcohol; (b) epoxidation reaction of the esters obtained in step (a); and (c) nucleophilic substitution reaction of the epoxidated esters obtained in step (b) using a branched aliphatic alcohol. The present invention also describes a biolubricant obtained from the process. More specifically, a biolubricant is described that is produced from a ricinoleic fatty acid, whose formula is illustrated in FIG. 1 of the present invention, and where R1 is a hydroxyl or it is from the formula R3COO−, with R3 being an alkyl radical C1-C3, preferably a methyl radical; and R2 consists of a straight chain of hydrocarbons C4-C8 and a branched chain of hydrocarbons C1-C3.
-
公开(公告)号:US11066359B2
公开(公告)日:2021-07-20
申请号:US16484817
申请日:2018-02-08
Applicant: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
Inventor: Mathew Gerald Lyman , Lawrence Dugan , Roald N. Leif , Bonnee Rubinfeld , Brian E. Souza , Carlos A. Valdez
IPC: C07C305/06 , C07C69/675 , C07C69/708
Abstract: Biodegradable surfactants are described, in which an amphiphilic heteroatom containing hydrocarbon optionally comprising at least one counterion (Z), and related compositions, methods and systems. Biodegradable surfactant described herein has an aHLB value in accordance with equation (1): aHLB=20*Gh/(Gh−Gt) (1) wherein Gh is the Group Number of a hydrophilic head portion of the biodegradable surfactant optionally comprising the at least one counterion (Z), and Gt is the Group Number of a hydrophobic tail portion of the biodegradable surfactant. A biodegradable surfactant in the sense of the disclosure can be tuned to a set hydrophilic-lipophilic balance (aHLB) by selectively modifying at least one tuning moiety of the biodegradable surfactants to provide tuned biodegradable surfactants having an increase or decrease in their adjusted hydrophilic-lipophilic balance (aHLB).
-
公开(公告)号:US20210009501A1
公开(公告)日:2021-01-14
申请号:US16936256
申请日:2020-07-22
Applicant: CORSAIR PHARMA, INC.
Inventor: Xiaoming ZHANG , Meenakshi S. VENKATRAMAN , Cyrus K. BECKER
IPC: C07C69/734 , C07C69/732 , C07C69/013 , C07C69/26 , C07C69/675 , C07C69/708 , C07C69/712 , C07C69/96 , C07D303/48 , A61K9/00 , A61K9/70 , A61K31/216 , A61K45/06
Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US20200181103A1
公开(公告)日:2020-06-11
申请号:US16509963
申请日:2019-07-12
Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
Inventor: Thomas S. Scanlan , Andrew Placzek , Tapasree Banerji , Sky Ferrara , James Matthew Meinig
IPC: C07D295/088 , C07D309/10 , C07D233/64 , C07D211/44 , C07D211/42 , C07D211/22 , C07D207/08 , C07D205/04 , C07C237/12 , C07C229/08 , C07C69/708 , C07H13/04 , C07C69/736 , C07C237/08 , C07C235/06 , C07C229/36 , C07C219/06 , A61P25/00
Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
-
-
-
-
-
-
-
-
-